2022
DOI: 10.1016/j.jacr.2022.05.006
|View full text |Cite
|
Sign up to set email alerts
|

Statement from the ACR Committee on Drugs and Contrast Media on the Intravenous Iodinated Contrast Media Shortage

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
29
0
2

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 30 publications
(31 citation statements)
references
References 0 publications
0
29
0
2
Order By: Relevance
“…Hence, angiographic outcomes, radiographic metrics and immediate complication rates were not adversely impacted with this strategy. Contrast conservation measures such as this are especially important in times of uncertainty to be able to continue to provide life-saving procedures such as MT 12 13. The overall contrast conservation per MT procedure was close to 85 mL from modifications to both pre-MT imaging (70 mL) and the MT procedure itself (15 mL).…”
Section: Discussionmentioning
confidence: 92%
“…Hence, angiographic outcomes, radiographic metrics and immediate complication rates were not adversely impacted with this strategy. Contrast conservation measures such as this are especially important in times of uncertainty to be able to continue to provide life-saving procedures such as MT 12 13. The overall contrast conservation per MT procedure was close to 85 mL from modifications to both pre-MT imaging (70 mL) and the MT procedure itself (15 mL).…”
Section: Discussionmentioning
confidence: 92%
“…Our steps mirrored the strategic actions taken by multiple other institutions and are consistent with ACR recommendations with overarching goals of extending contrast supply run rate and reducing waste. [10,17] consumption [Figure 3]. Similarly, there was an increase in available contrast from GE in mid-June as the production at the Shanghai plant expanded.…”
Section: Overarching Strategy and Background Analysismentioning
confidence: 99%
“…Given increased clinical reliance on CT, which often includes the need for intravenous contrast, for the diagnosis and follow-up of a variety of conditions and its associated dramatic utilization growth over recent decades [ 2 ], disruptions in patient care have already occurred and are anticipated to continue. The ACR recently released recommendations to help mitigate that impact [ 3 ], and individual centers are beginning to share their institutional approaches and experience [ 4 , 5 ].…”
Section: Description Of the Problemmentioning
confidence: 99%
“…Emerging published iodinated contrast reduction guidelines and institutional implementation strategies [ 3 , 4 , 5 ] largely focus on efficiently and robustly identifying scenarios in which contrast use may be minimized or avoided by using alternative imaging modalities, contrast agents, or protocols that reduce or minimize waste resulting from individual doses. In implementing these strategies, radiology practices and departments may find their greatest mitigation impact focusing on the most frequently used CT services outlined herein, and particularly abdominal/pelvic and chest CT in the emergency department and hospital outpatient settings as well as brain and head/neck CTA in the emergency department and hospital inpatient settings.…”
Section: Outcomes and Limitationsmentioning
confidence: 99%